PS-067 Peripheral neuropathy induced by oxaliplatin: risk factors
T Rusu, I Ekoume, S Henault, E Malaurie, S Poullain - 2015 - ejhp.bmj.com
Background Oxaliplatin is widely used in the treatment of solid cancers. The main limit of use
is the occurrence of peripheral neuropathy (PN). The principal predisposing risk factors (RF) …
is the occurrence of peripheral neuropathy (PN). The principal predisposing risk factors (RF) …
[CITATION][C] Patient safety and risk management
T Rusu, I Ekoume, E Malaurie, S Poullain - European journal of hospital pharmacy, 2015
[CITATION][C] Hématémèses et fibroscopie oesogastroduodénale au Gabon: une expérience de dix ans
…, JB BOGUIKOUMA, I EKOUME… - La Semaine des …, 1995 - pascal-francis.inist.fr
Hématémèses et fibroscopie oesogastroduodénale au Gabon : une expérience de dix ans
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
[CITATION][C] Impact of antiemetic prescriptions updating in oncology
N Thiriat, I Ekoume, S Poullain… - …, 2013 - … VAN GODEWIJCKSTRAAT 30 …
[CITATION][C] ESOGASTROINTESTINAL FIBEROPTIC ENDOSCOPY FINDINGS IN PATIENTS EVALUATED FOR HEMATEMESIS IN GABON OVER A 10-YEAR …
…, JB Boguikouma, I Ekoume… - SEMAINE …, 1995 - EXPANSION SCI FRANCAISE 31 …